Publications by authors named "Neil Gallagher"

Claim this Profile
A
A widespread electrical brain network encodes anxiety in health and depressive states.
Dalton N Hughes, Michael Hunter Klein, Kathryn Katsue Walder-Christensen, Gwenaëlle E Thomas, Yael Grossman, Neil M Gallagher

bioRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generalizing CNNs to Graphs with Learnable Neighborhood Quantization.
Isaac Osafo Nkansah, Neil Gallagher, Ruchi Sandilya, Conor Liston, Logan Grosenick

Adv Neural Inf Process Syst· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electome network factors: Capturing emotional brain networks related to health and disease.
Kathryn Walder-Christensen, Karim Abdelaal, Hunter Klein, Gwenaëlle E Thomas, Neil M Gallagher

Cell Rep Methods· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supervising the Decoder of Variational Autoencoders to Improve Scientific Utility.
Liyun Tu, Austin Talbot, Neil M Gallagher, David E Carlson

IEEE Trans Signal Process· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prenatal environmental stressors impair postnatal microglia function and adult behavior in males.
Carina L Block, Oznur Eroglu, Stephen D Mague, Caroline J Smith, Alexis M Ceasrine, Neil M Gallagher

Cell Rep· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain-wide electrical dynamics encode individual appetitive social behavior.
Stephen D Mague, Austin Talbot, Cameron Blount, Kathryn K Walder-Christensen, Lara J Duffney, Neil M Gallagher

Neuron· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Directed Spectral Measures Improve Latent Network Models Of Neural Populations.
Neil M Gallagher, Kafui Dzirasa, David Carlson

Adv Neural Inf Process Syst· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Overview of Outcomes Associated With Early Versus Late Tracheostomy From a National Standpoint.
Guiseppe Filice, Palak Patel, Priyaranjan Kata, Anish Kanukuntla, Vraj Patel, Neil Gallagher

Cureus· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of FMRFamide-related peptides and co-localization with glutamate in Cupiennius salei, an invertebrate model system.
Emily A Tarr, Brian M Fidler, Kyrstin E Gee, Carly M Anderson, Anna K Jager, Neil M Gallagher

Cell Tissue Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain-wide Electrical Spatiotemporal Dynamics Encode Depression Vulnerability.
Rainbo Hultman, Kyle Ulrich, Benjamin D Sachs, Cameron Blount, David E Carlson, Neil M Gallagher

Cell· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamically Timed Stimulation of Corticolimbic Circuitry Activates a Stress-Compensatory Pathway.
David Carlson, Lisa K David, Neil M Gallagher, Mai-Anh T Vu, Matthew Shirley

Biol Psychiatry· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of gadolinium enhanced cardiovascular MRI to differentiate Fabry's disease from other causes of hypertrophic cardiomyopathy.
Edward T D Hoey, Ed Neil-Gallagher

Postgrad Med J· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent use of proton pump inhibitors or H2 blockers did not adversely affect nilotinib efficacy in patients with chronic myeloid leukemia.
Ophelia Q P Yin, Frank J Giles, Michele Baccarani, Philipp le Coutre, Ovidiu Chiparus, Neil Gallagher

Cancer Chemother Pharmacol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding Nilotinib Access in Clinical Trials (ENACT), an open-label multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase or blast crisis.
Franck E Nicolini, Tamas Masszi, Zhixiang Shen, Neil J Gallagher, Saengsuree Jootar

Leuk Lymphoma· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic and exposure-response analysis of nilotinib in patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase.
Richard A Larson, Ophelia Q P Yin, Andreas Hochhaus, Giuseppe Saglio, Richard E Clark, Neil J Gallagher

Eur J Clin Pharmacol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding Nilotinib Access in Clinical Trials (ENACT): an open-label, multicenter study of oral nilotinib in adult patients with imatinib-resistant or imatinib-intolerant Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase.
Franck E Nicolini, Anna Turkina, Zhi-Xiang Shen, Neil Gallagher, Saengsuree Jootar

Cancer· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial.
Hagop M Kantarjian, Andreas Hochhaus, Giuseppe Saglio, Carmino De Souza, Ian W Flinn, Neil J Gallagher

Lancet Oncol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of nilotinib on single-dose warfarin pharmacokinetics and pharmacodynamics: a randomized, single-blind, two-period crossover study in healthy subjects.
Ophelia Q P Yin, Neil Gallagher, Deirdre Fischer, Lily Zhao, Wei Zhou

Clin Drug Investig· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results.
Hagop M Kantarjian, Francis J Giles, Kapil N Bhalla, Javier Pinilla-Ibarz, Richard A Larson, Neil J Gallagher

Blood· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib.
Paul W Manley, Nikolaus Stiefl, Sandra W Cowan-Jacob, Susan Kaufman, Jürgen Mestan, Neil Gallagher

Bioorg Med Chem· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the proton pump inhibitor esomeprazole on the oral absorption and pharmacokinetics of nilotinib.
Ophelia Q P Yin, Neil Gallagher, Deirdre Fischer, Eren Demirhan, Wei Zhou

J Clin Pharmacol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.
Giuseppe Saglio, Dong-Wook Kim, Surapol Issaragrisil, Philipp le Coutre, Gabriel Etienne, Neil Gallagher

N Engl J Med· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of grapefruit juice on the pharmacokinetics of nilotinib in healthy participants.
Ophelia Q P Yin, Neil Gallagher, Ai Li, Wei Zhou, Robert Harrell

J Clin Pharmacol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of hepatic impairment on the pharmacokinetics of nilotinib: an open-label, single-dose, parallel-group study.
Ophelia Q P Yin, Neil Gallagher, Chiaki Tanaka, Deirdre Fisher, Venkat Sethuraman

Clin Ther· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase.
Timothy Hughes, Giuseppe Saglio, Susan Branford, Simona Soverini, Dong-Wook Kim, Neil Gallagher

J Clin Oncol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis